SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001679082-22-000032
Filing Date
2022-01-26
Accepted
2022-01-26 07:09:16
Documents
62
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q myov-20211231.htm   iXBRL 10-Q 1755308
2 EX-31.1 a12312021myovantex311.htm EX-31.1 10722
3 EX-31.2 a12312021myovantex312.htm EX-31.2 10881
4 EX-32.1 a12312021myovantex321.htm EX-32.1 6497
5 EX-32.2 a12312021myovantex322.htm EX-32.2 6285
  Complete submission text file 0001679082-22-000032.txt   6720299

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT myov-20211231.xsd EX-101.SCH 51606
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT myov-20211231_cal.xml EX-101.CAL 59117
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT myov-20211231_def.xml EX-101.DEF 239418
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT myov-20211231_lab.xml EX-101.LAB 545361
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT myov-20211231_pre.xml EX-101.PRE 362542
56 EXTRACTED XBRL INSTANCE DOCUMENT myov-20211231_htm.xml XML 1024675
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37929 | Film No.: 22555676
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences